Autopsy report · NCT05327855

Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI)

“Withdrawn based on business decision, no participants enrolled”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Valo Health, Inc.

Sponsor type

Industry

Conditions

Myocardial Infarction

Interventions

OPL-0301 Dose 1; OPL-0301 Dose 2; Placebo

Participants

0

Trials that died the same way

• AIM4 AI and Mechanistic Modeling in Molecular Medicine
  “Withdrawn No Participants Enrolled” (83% match in meaning)
• Sucrosomial Vs Intravenous Iron for Preoperative Anemia
  “Study withdrawn due to lack of funding and the company's decision not to pursue the IND. No participants were enrolled.” (75% match in meaning)
• IC14 in Adult Patients With Dengue Fever
  “withdrawn, no enrollment” (74% match in meaning)
• MA-CEAL Community Health Ambassador Program
  “Withdrawn for study design changes prior to implementation of the study. No participants were enrolled.” (73% match in meaning)
• A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes
  “Study was withdrawn prior to enrolment due to business decision.” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.